Eidelman Virant Capital - BIOSCRIP INC ownership

BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 96 filers reported holding BIOSCRIP INC in Q2 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.5%.

Quarter-by-quarter ownership
Eidelman Virant Capital ownership history of BIOSCRIP INC
ValueSharesWeighting
Q2 2017$67,000
-71.8%
25,000
-82.1%
0.04%
-76.2%
Q1 2017$238,000
+4.4%
140,000
-36.4%
0.16%
+26.2%
Q4 2016$228,000
-80.3%
220,000
-45.0%
0.13%
-81.7%
Q3 2016$1,156,000
+7.9%
400,000
+852.4%
0.71%
+8.0%
Q2 2016$1,071,000
-99.8%
42,000
-82.5%
0.66%
+100.9%
Q1 2016$484,800,000
+184938.2%
240,000
+60.0%
0.33%
+108.9%
Q4 2015$262,000150,0000.16%
Other shareholders
BIOSCRIP INC shareholders Q2 2017
NameSharesValueWeighting ↓
Coliseum Capital Management, LLC 5,622,410$5,847,0002.64%
NORTH TIDE CAPITAL, LLC 8,500,000$8,840,0001.51%
WYNNEFIELD CAPITAL INC 3,700,000$3,848,0001.39%
Alta Fundamental Advisers LLC 2,330,774$2,424,0001.20%
ARDSLEY ADVISORY PARTNERS LP 6,350,000$6,604,0001.09%
Camber Capital Management LP 10,180,000$10,587,0000.55%
PERKINS CAPITAL MANAGEMENT INC 298,000$310,0000.34%
Hawk Ridge Capital Management 340,429$354,0000.18%
Eidelman Virant Capital 220,000$228,0000.13%
ROANOKE ASSET MANAGEMENT CORP/ NY 227,280$236,0000.11%
View complete list of BIOSCRIP INC shareholders